Shield Bio Company
Shield Bio - using ultra-fast sequencing to prevent antibiotic resistance
Investors
.png)
(Reupload).png)
Technology:
Сancer Diagnostics
Industry:
Deep Diagnostics
Headquarters:
San Jose, California, United States
Founded Date:
04.05.2016
Employees Number:
11-50
Funding Status:
Early Stage Venture
Investors Number:
20
Total Funding:
$12.1M
Estimated Revenue:
Less than $1M
Last Funding Type:
Series A
Register and Claim Ownership